TECH  valuation analysis

Name: Bio-Techne Corporation
Description: Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 02, 2021
Market cap: $13.81B (364th)
Sales(TTM): $798.97M (968th)
Earnings(TTM): $174.82M (548th)

FFER: 1.97 (why)
Actual price: $356.21
FFEThis is Bio-Techne Corporation's the estimated price. FFEs are the denominator of the FFER ratio.: $200.02
Quantile: TECH is very expensive given its fundamentals.
Prices as of EOD 2021-03-05
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Bio-Techne Corporation
"Biotechnology" industry
Sales / MarketCap
Bio-Techne Corporation
"Biotechnology" industry
Book / MarketCap
Bio-Techne Corporation
"Biotechnology" industry
Equity / Assets
Bio-Techne Corporation
"Biotechnology" industry